Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(4-Bromophenyl)pyrrolidine-2-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

28311-23-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 28311-23-1 Structure
  • Basic information

    1. Product Name: 4-(4-Bromophenyl)pyrrolidine-2-one
    2. Synonyms: 4-(4-Bromophenyl)pyrrolidine-2-one;4-(4-Bromophenyl)-2-pyrrolidinone;4-(4-broMophenyl)pyrrolidin-2-one
    3. CAS NO:28311-23-1
    4. Molecular Formula: C10H10BrNO
    5. Molecular Weight: 240.11
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 28311-23-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.485
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-(4-Bromophenyl)pyrrolidine-2-one(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-(4-Bromophenyl)pyrrolidine-2-one(28311-23-1)
    11. EPA Substance Registry System: 4-(4-Bromophenyl)pyrrolidine-2-one(28311-23-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 28311-23-1(Hazardous Substances Data)

28311-23-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 28311-23-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,3,1 and 1 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 28311-23:
(7*2)+(6*8)+(5*3)+(4*1)+(3*1)+(2*2)+(1*3)=91
91 % 10 = 1
So 28311-23-1 is a valid CAS Registry Number.

28311-23-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-bromophenyl)pyrrolidin-2-one

1.2 Other means of identification

Product number -
Other names F2147-0755

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28311-23-1 SDS

28311-23-1Relevant articles and documents

PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF

-

, (2020/01/08)

Disclosed herein is a compound of Formula (AIII) or (III), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.

Design, synthesis, and biological evaluation of a dansyled amino acid derivative as an imaging agent for apoptosis

Zeng, Wenbin,Miao, Weimin,Kabalka, George,Puil, Michael Le,Biggerstaff, John,Townsend, David

scheme or table, p. 6429 - 6432 (2009/04/06)

To develop a small molecule-based biomarker for in vivo apoptosis imaging, a dansyled amino acid derivative (BNSBA) was designed and synthesized in good yield. The biological evaluation demonstrated that BNSBA selectively binds to apoptotic cancer cells and is localized within the cytoplasm of cells that bound annexin V on the plasma membrane.

HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

-

Page/Page column 233-234, (2008/12/05)

Provided herein are Heteroaryl Compounds having the following structure: (I) wherein R1, R2, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 28311-23-1